Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

3/31/2026
Impact: -85
Healthcare

Nanobiotix (NASDAQ: NBTX) reported a fiscal year loss of $(0.58) per share, a significant decline from earnings of $1.56 per share in the previous year, marking a 137.18% decrease. The company's quarterly sales reached $37.943 million, falling short of the analyst consensus estimate of $165.540 million by 77.08%, although this represents a 189.75% increase from $13.095 million in the same quarter last year.

AI summary, not financial advice

Share: